Skip to main content
. 2023 Jan 19;12(6):539–549. doi: 10.1159/000529143

Fig. 2.

Fig. 2

Kaplan-Meier survival curves between surgical resection (SR) and transarterial chemoembolization (TACE) in patients with BCLC-A/B HCC beyond the Milan criteria with any tumor burden (a), low tumor burden (b), intermediate tumor burden (c) and high tumor burden (d) defined by the seven-eleven criteria.